Joanne Carson

University of New South Wales

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (12)

Jasmine Yee

University of Sydney

AUSTRALIA

View details

Sofia Bartlett

Adjunct Professor

The University of British Columbia

CANADA

View details

Tanya Applegate

Senior Lecturer

University of New South Wales

AUSTRALIA

View details

Joshua Dawe

University of Bristol

UNITED KINGDOM

View details

Margaret Hellard

Burnet Institute

AUSTRALIA

View details

Behzad Hajarizadeh

University of New South Wales

AUSTRALIA

View details

Janaki Amin

Macquarie University

AUSTRALIA

View details

Renjy Nelson

Associate Professor

University of Adelaide

AUSTRALIA

View details

Andri Rauch

Chief Physician and Deputy Director

University Hospital of Bern

SWITZERLAND

View details

Jisoo Amy Kwon

Lecturer

AUSTRALIA

View details

Phillip Read

New South Wales Department of Planning and Environment

AUSTRALIA

View details

Marta Rava

Instituto de Salud Carlos III

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joanne Carson

Research Interests

Explore related searches

Contact this professor

Articles (20)

The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study

Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

Incidence of hepatitis C virus infection in the prison setting: The SToP‐C study

Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia

Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014–2023)

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis

Effectiveness of direct‐acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real‐world cohort (REACH‐C)

Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021

Hepatitis C Virus Reinfection in a Real-world Cohort of Homeless-experienced Individuals in Boston

National trends in retreatment of HCV due to reinfection or treatment failure in Australia

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case–Control Diagnostic Validation Study

Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study

Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort

Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort

Collaborators (12)

Jasmine Yee

Sofia Bartlett

Tanya Applegate

Joshua Dawe

Margaret Hellard

Behzad Hajarizadeh

Janaki Amin

Renjy Nelson

Andri Rauch

Jisoo Amy Kwon

Phillip Read

Marta Rava

Make your next move.